Search
Bypass Angioplasty Revascularization Investivation (BARI)
Randomized trial, PTCA vs CABG in patients with multivessel coronary artery disease.
12 years of followup
Results:
1) compared with PTCA, CABG associated with greater improvement in physical functioning in 1st 3 years, but not after
2) CABG initially more expensive than PTCA (53%) but not averaged over 12 years $123,000 vs $121,000 (over 12 years)
Related
coronary artery bypass grafting (CABG)
percutaneous transluminal coronary angioplasty (PTCA)
General
clinical trial
References
Journal Watch 24(24):184, 2004
Hlatky MA, Boothroyd DB, Melsop KA, Brooks MM, Mark DB, Pitt B,
Reeder GS, Rogers WJ, Ryan TJ, Whitlow PL, Wiens RD.
Medical costs and quality of life 10 to 12 years after randomization
to angioplasty or bypass surgery for multivessel coronary artery disease.
Circulation. 2004 Oct 5;110(14):1960-6. Epub 2004 Sep 27.
PMID: 15451795